14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Mar 17, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 16, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 15, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 14, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 11, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 10, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 09, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 08, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 07, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 04, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 03, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 02, 2022 $182.50 $182.50 $182.50 $182.50 0
Mar 01, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 28, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 25, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 24, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 23, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 22, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 18, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 17, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 16, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 15, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 14, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 11, 2022 $182.50 $182.50 $182.50 $182.50 0
Feb 10, 2022 $182.50 $182.50 $182.50 $182.50 0
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT